Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statement Detail (Tables)

v3.22.2
Condensed Consolidated Financial Statement Detail (Tables)
6 Months Ended
Jun. 30, 2022
Consolidated Financial Statements  
Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

June 30, 

December 31, 

    

2022

    

2021

Accrued incentive compensation

461

55

Accrued legal and accounting fees

424

295

Accrued payroll and benefits

 

121

 

135

Other accrued liabilities

20

40

Total

$

1,026

$

525

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Numerator

 

  

 

  

 

  

 

  

Net loss

$

(4,670)

$

(2,237)

$

(6,950)

$

(9,610)

Less: Series A accumulated dividends

 

(530)

 

(530)

 

(1,061)

 

(1,061)

Less: Series B accumulated dividends

(838)

(763)

(1,675)

(763)

Net loss attributable to common stockholders, basic and diluted

$

(6,038)

$

(3,530)

$

(9,686)

$

(11,434)

 

 

Denominator

 

 

 

 

Weighted average shares used in computing basic and diluted net loss per share attributable to common stockholders

 

11,421

11,285

 

11,376

 

11,263

Basic and diluted net loss per share attributable to common stockholders

$

(0.53)

(0.31)

$

(0.85)

$

(1.02)

Outstanding Securities Considered Anti-Dilutive

The following table shows the weighted-average shares from outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Convertible preferred stock

5,003

5,003

5,003

5,003

Common stock options

 

889

 

377

 

813

318

Warrants for common stock

 

6

 

5

 

6

5

Total

 

5,898

 

5,385

 

5,822

 

5,326